Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

NCT01381510 · clinicaltrials.gov ↗

COMPLETED

Status

54459

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: 5-alpha Reductase Inhibitor (5ARI)

Sponsor

GlaxoSmithKline